Home

Zydus Lifesciences Ltd Quarterly Result

Image

Zydus Lifesciences Ltd

NSE: ZYDUSLIFE

Net Profit - Last Quarter

₹ 898.1 Cr.

Last updated on: Jan 22, 2025

Zydus Lifesciences Ltd Quarterly Results Key Highlights

  • The revenue of Zydus Lifesciences Ltd for the Sep '24 is ₹ 5305 crore as compare to the Jun '24 revenue of ₹ 6270 crore.
  • This represent the decline of -15.39%a1# The ebitda of Zydus Lifesciences Ltd for the Sep '24 is ₹ 1529 crore as compare to the Jun '24 ebitda of ₹ 2147 crore.
  • This represent the decline of -28.75%a1# The net profit of Zydus Lifesciences Ltd for the Sep '24 is ₹ 898.1 crore as compare to the Jun '24 net profit of ₹ 1463 crore.
  • This represent the decline of -38.64%a1#.

Zydus Lifesciences Ltd Quarterly Results Analysis

Market Price of Zydus Lifesciences Ltd

1M

1Y

3Y

5Y

Monitoring Zydus Lifesciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Jan 2025978.85
21 Jan 2025985.75
20 Jan 2025995.05
17 Jan 2025994.15
16 Jan 2025988.8
15 Jan 2025984.8
14 Jan 20251000.8
13 Jan 2025974.3
10 Jan 20251004.05
09 Jan 20251009.4

Historical Revenue of Zydus Lifesciences Ltd

No data available

* All values are in crore

Historical EBITDA of Zydus Lifesciences Ltd

No data available

* All values are in crore

Historical Net Profit of Zydus Lifesciences Ltd

No data available

* All values are in crore

Zydus Lifesciences Ltd News Hub

Zydus Life gains as Q1 PAT climbs 31% YoY to Rs 1,420 cr

Revenue from operations jumped 20.77% year on year (YoY) to Rs 6,207.5 crore in the quareter ended 3

Read more

09 Aug 2024

Zydus Lifesciences consolidated net profit rises 30.64% in the June 2024 quarter

Net profit of Zydus Lifesciences rose 30.64% to Rs 1419.90 crore in the quarter ended June 2024 as a

Read more

09 Aug 2024

Zydus receives USFDA approval for Valbenazine Capsules

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (

Read more

09 Aug 2024

Zydus Lifesciences Ltd soars 1.83%, rises for third straight session

Zydus Lifesciences Ltd is up for a third straight session in a row. The stock is quoting at Rs 1296.

Read more

08 Aug 2024

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

FAQs for Quarterly Results of Zydus Lifesciences Ltd

What key financial metrics are included in Zydus Lifesciences Ltd's quarterly results?

Key financial metrics in Zydus Lifesciences Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Zydus Lifesciences Ltd announce its quarterly results?

Zydus Lifesciences Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Zydus Lifesciences Ltd's quarterly performance impact its stock price?

Zydus Lifesciences Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Zydus Lifesciences Ltd's quarterly results on dividends?

The impact of Zydus Lifesciences Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Zydus Lifesciences Ltd's quarterly results?

Yes, Zydus Lifesciences Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions